Structural basis of phosphatidylinositol 3-kinase C2α function.


Journal

Nature structural & molecular biology
ISSN: 1545-9985
Titre abrégé: Nat Struct Mol Biol
Pays: United States
ID NLM: 101186374

Informations de publication

Date de publication:
03 2022
Historique:
received: 13 07 2021
accepted: 21 01 2022
pubmed: 9 3 2022
medline: 20 4 2022
entrez: 8 3 2022
Statut: ppublish

Résumé

Phosphatidylinositol 3-kinase type 2α (PI3KC2α) is an essential member of the structurally unresolved class II PI3K family with crucial functions in lipid signaling, endocytosis, angiogenesis, viral replication, platelet formation and a role in mitosis. The molecular basis of these activities of PI3KC2α is poorly understood. Here, we report high-resolution crystal structures as well as a 4.4-Å cryogenic-electron microscopic (cryo-EM) structure of PI3KC2α in active and inactive conformations. We unravel a coincident mechanism of lipid-induced activation of PI3KC2α at membranes that involves large-scale repositioning of its Ras-binding and lipid-binding distal Phox-homology and C-C2 domains, and can serve as a model for the entire class II PI3K family. Moreover, we describe a PI3KC2α-specific helical bundle domain that underlies its scaffolding function at the mitotic spindle. Our results advance our understanding of PI3K biology and pave the way for the development of specific inhibitors of class II PI3K function with wide applications in biomedicine.

Identifiants

pubmed: 35256802
doi: 10.1038/s41594-022-00730-w
pii: 10.1038/s41594-022-00730-w
pmc: PMC8930771
doi:

Substances chimiques

Lipids 0
Phosphatidylinositol 3-Kinase EC 2.7.1.137

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

218-228

Informations de copyright

© 2022. The Author(s).

Références

Bilanges, B., Posor, Y. & Vanhaesebroeck, B. PI3K isoforms in cell signalling and vesicle trafficking. Nat. Rev. Mol. Cell Biol. 20, 515–534 (2019).
pubmed: 31110302 doi: 10.1038/s41580-019-0129-z
Toker, A. & Cantley, L. C. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387, 673–676 (1997).
pubmed: 9192891 doi: 10.1038/42648
Wymann, M. P. & Schneiter, R. Lipid signalling in disease. Nat. Rev. Mol. Cell Biol. 9, 162–176 (2008).
pubmed: 18216772 doi: 10.1038/nrm2335
Burke, J. E. Structural basis for regulation of phosphoinositide kinases and their involvement in human disease. Mol. Cell 71, 653–673 (2018).
pubmed: 30193094 doi: 10.1016/j.molcel.2018.08.005
Pacold, M. E. et al. Crystal structure and functional analysis of Ras binding to its effector phosphoinositide 3-kinase gamma. Cell 103, 931–943 (2000).
pubmed: 11136978 doi: 10.1016/S0092-8674(00)00196-3
Walker, E. H., Perisic, O., Ried, C., Stephens, L. & Williams, R. L. Structural insights into phosphoinositide 3-kinase catalysis and signalling. Nature 402, 313–320 (1999).
pubmed: 10580505 doi: 10.1038/46319
Rostislavleva, K. et al. Structure and flexibility of the endosomal Vps34 complex reveals the basis of its function on membranes. Science 350, aac7365 (2015).
pubmed: 26450213 pmcid: 4601532 doi: 10.1126/science.aac7365
Stjepanovic, G., Baskaran, S., Lin, M. G. & Hurley, J. H. Vps34 kinase domain dynamics regulate the autophagic PI 3-kinase complex. Mol. Cell 67, 528–534 e3 (2017).
pubmed: 28757208 pmcid: 5573195 doi: 10.1016/j.molcel.2017.07.003
Braccini, L. et al. PI3K-C2gamma is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling. Nat. Commun. 6, 7400 (2015).
pubmed: 26100075 doi: 10.1038/ncomms8400
Marat, A. L. et al. mTORC1 activity repression by late endosomal phosphatidylinositol 3,4-bisphosphate. Science 356, 968–972 (2017).
pubmed: 28572395 doi: 10.1126/science.aaf8310
Boukhalfa, A. et al. PI3KC2alpha-dependent and VPS34-independent generation of PI3P controls primary cilium-mediated autophagy in response to shear stress. Nat. Commun. 11, 294 (2020).
pubmed: 31941925 pmcid: 6962367 doi: 10.1038/s41467-019-14086-1
Campa, C. C. et al. Rab11 activity and PtdIns(3)P turnover removes recycling cargo from endosomes. Nat. Chem. Biol. 14, 801–810 (2018).
pubmed: 29915378 doi: 10.1038/s41589-018-0086-4
Franco, I. et al. PI3K class II alpha controls spatially restricted endosomal PtdIns3P and Rab11 activation to promote primary cilium function. Dev. Cell 28, 647–658 (2014).
pubmed: 24697898 pmcid: 4042153 doi: 10.1016/j.devcel.2014.01.022
Gulluni, F., De Santis, M. C., Margaria, J. P., Martini, M. & Hirsch, E. Class II PI3K functions in cell biology and disease. Trends Cell Biol. 29, 339–359 (2019).
pubmed: 30691999 doi: 10.1016/j.tcb.2019.01.001
Posor, Y. et al. Spatiotemporal control of endocytosis by phosphatidylinositol-3,4-bisphosphate. Nature 499, 233–237 (2013).
pubmed: 23823722 doi: 10.1038/nature12360
Wang, H. et al. Phosphatidylinositol 3,4-bisphosphate synthesis and turnover are spatially segregated in the endocytic pathway. J. Biol. Chem. 295, 1091–1104 (2020).
pubmed: 31831620 doi: 10.1016/S0021-9258(17)49918-2
Aki, S., Yoshioka, K., Takuwa, N. & Takuwa, Y. TGFbeta receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2alpha-, and INPP4B-mediated phosphoinositide conversions. Mol. Biol. Cell 31, 360–372 (2020).
pubmed: 31913757 pmcid: 7183790 doi: 10.1091/mbc.E19-11-0662
Biswas, K. et al. Essential role of class II phosphatidylinositol-3-kinase-C2alpha in sphingosine 1-phosphate receptor-1-mediated signaling and migration in endothelial cells. J. Biol. Chem. 288, 2325–2339 (2013).
pubmed: 23192342 doi: 10.1074/jbc.M112.409656
Yoshioka, K. et al. Endothelial PI3K-C2alpha, a class II PI3K, has an essential role in angiogenesis and vascular barrier function. Nat. Med. 18, 1560–1569 (2012).
pubmed: 22983395 doi: 10.1038/nm.2928
Islam, S. et al. Class II phosphatidylinositol 3-kinase alpha and beta isoforms are required for vascular smooth muscle Rho activation, contraction and blood pressure regulation in mice. J. Physiol. Sci. 70, 18 (2020).
pubmed: 32192434 pmcid: 7082390 doi: 10.1186/s12576-020-00745-2
Abere, B. et al. Kaposi’s sarcoma-associated herpesvirus nonstructural membrane protein pK15 recruits the class II phosphatidylinositol 3-kinase PI3K-C2alpha to activate productive viral replication. J. Virol. 92, e00544 (2018).
Polachek, W. S. et al. High-throughput small interfering RNA screening identifies phosphatidylinositol 3-kinase class ii alpha as important for production of human cytomegalovirus virions. J. Virol. 90, 8360–8371 (2016).
pubmed: 27412598 pmcid: 5008103 doi: 10.1128/JVI.01134-16
Mountford, J. K. et al. The class II PI 3-kinase, PI3KC2alpha, links platelet internal membrane structure to shear-dependent adhesive function. Nat. Commun. 6, 6535 (2015).
pubmed: 25779105 doi: 10.1038/ncomms7535
Valet, C. et al. Essential role of class II PI3K-C2alpha in platelet membrane morphology. Blood 126, 1128–1137 (2015).
pubmed: 26109204 doi: 10.1182/blood-2015-03-636670
Tiosano, D. et al. Mutations in PIK3C2A cause syndromic short stature, skeletal abnormalities, and cataracts associated with ciliary dysfunction. PLoS Genet. 15, e1008088 (2019).
pubmed: 31034465 pmcid: 6508738 doi: 10.1371/journal.pgen.1008088
Gulluni, F. et al. Mitotic spindle assembly and genomic stability in breast cancer require PI3K-C2alpha scaffolding function. Cancer Cell 32, 444–459 e7 (2017).
pubmed: 29017056 doi: 10.1016/j.ccell.2017.09.002
Young, L. N., Goerdeler, F. & Hurley, J. H. Structural pathway for allosteric activation of the autophagic PI 3-kinase complex I. Proc. Natl Acad. Sci. USA 116, 21508–21513 (2019).
pubmed: 31591221 pmcid: 6815113 doi: 10.1073/pnas.1911612116
Selvadurai, M. V. et al. Disrupting the platelet internal membrane via PI3KC2alpha inhibition impairs thrombosis independently of canonical platelet activation. Sci. Transl. Med. 12, eaar8430 (2020).
Alliouachene, S. et al. Inactivation of class II PI3K-C2alpha induces leptin resistance, age-dependent insulin resistance and obesity in male mice. Diabetologia 59, 1503–1512 (2016).
pubmed: 27138914 pmcid: 4901096 doi: 10.1007/s00125-016-3963-y
Wang, H. et al. Autoregulation of class ii alpha PI3K activity by its lipid-binding PX-C2 domain module. Mol. Cell 71, 343–351 e4 (2018).
pubmed: 30029007 doi: 10.1016/j.molcel.2018.06.042
Miller, S. et al. Shaping development of autophagy inhibitors with the structure of the Lipid Kinase Vps34. Science 327, 1638–1642 (2010).
pubmed: 20339072 pmcid: 2860105 doi: 10.1126/science.1184429
Siempelkamp, B. D., Rathinaswamy, M. K., Jenkins, M. L. & Burke, J. E. Molecular mechanism of activation of class IA phosphoinositide 3-kinases (PI3Ks) by membrane-localized HRas. J. Biol. Chem. 292, 12256–12266 (2017).
pubmed: 28515318 pmcid: 5519374 doi: 10.1074/jbc.M117.789263
Schoneberg, J. et al. Lipid-mediated PX-BAR domain recruitment couples local membrane constriction to endocytic vesicle fission. Nat. Commun. 8, 15873 (2017).
Miller, M. S. et al. Structural basis of nSH2 regulation and lipid binding in PI3Kalpha. Oncotarget 5, 5198–5208 (2014).
pubmed: 25105564 pmcid: 4170646 doi: 10.18632/oncotarget.2263
Wymann, M. P. & Schultz, C. The chemical biology of phosphoinositide 3-kinases. Chem. Bio. Chem. 13, 2022–2035 (2012).
pubmed: 22965647 doi: 10.1002/cbic.201200089
Yang, H. et al. mTOR kinase structure, mechanism and regulation. Nature 497, 217–223 (2013).
pubmed: 23636326 pmcid: 4512754 doi: 10.1038/nature12122
Chen, K. E., Tillu, V. A., Chandra, M. & Collins, B. M. Molecular basis for membrane recruitment by the PX and C2 domains of class II phosphoinositide 3-kinase-C2alpha. Structure 26, 1612–1625 e4 (2018).
pubmed: 30293811 doi: 10.1016/j.str.2018.08.010
Karaca, E., Melquiond, A. S., de Vries, S. J., Kastritis, P. L. & Bonvin, A. M. Building macromolecular assemblies by information-driven docking: introducing the HADDOCK multibody docking server. Mol. Cell Proteom. 9, 1784–1794 (2010).
doi: 10.1074/mcp.M000051-MCP201
Gaidarov, I., Smith, M. E., Domin, J. & Keen, J. H. The class II phosphoinositide 3-kinase C2alpha is activated by clathrin and regulates clathrin-mediated membrane trafficking. Mol. Cell 7, 443–449 (2001).
pubmed: 11239472 doi: 10.1016/S1097-2765(01)00191-5
Hon, W. C., Berndt, A. & Williams, R. L. Regulation of lipid binding underlies the activation mechanism of class IA PI3-kinases. Oncogene 31, 3655–3666 (2012).
pubmed: 22120714 doi: 10.1038/onc.2011.532
He, K. et al. Dynamics of phosphoinositide conversion in clathrin-mediated endocytic traffic. Nature 552, 410–414 (2017).
pubmed: 29236694 pmcid: 6263037 doi: 10.1038/nature25146
Phua, S. C. et al. Dynamic remodeling of membrane composition drives cell cycle through primary cilia excision. Cell 168, 264-+ (2017).
pubmed: 28086093 pmcid: 5660509 doi: 10.1016/j.cell.2016.12.032
Sparta, K. M., Krug, M., Heinemann, U., Mueller, U. & Weiss, M. S. Xdsapp20. J. Appl. Crystallogr. 49, 1085–1092 (2016).
doi: 10.1107/S1600576716004416
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix. Acta Crystallogr. D. Struct. Biol. 75, 861–877 (2019).
pubmed: 31588918 pmcid: 6778852 doi: 10.1107/S2059798319011471
Murshudov, G. N. et al. REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr. D. Biol. Crystallogr. 67, 355–367 (2011).
pubmed: 21460454 pmcid: 3069751 doi: 10.1107/S0907444911001314
Bricogne, G. Direct phase determination by entropy maximization and likelihood ranking: status report and perspectives. Acta Crystallogr. D. Biol. Crystallogr. 49, 37–60 (1993).
pubmed: 15299544 doi: 10.1107/S0907444992010400
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D. Biol. Crystallogr. 66, 486–501 (2010).
pubmed: 20383002 pmcid: 2852313 doi: 10.1107/S0907444910007493
Rohou, A. & Grigorieff, N. CTFFIND4: fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. 192, 216–221 (2015).
pubmed: 26278980 pmcid: 6760662
Scheres, S. H. RELION: implementation of a Bayesian approach to cryo-EM structure determination. J. Struct. Biol. 180, 519–530 (2012).
pubmed: 23000701 pmcid: 3690530 doi: 10.1016/j.jsb.2012.09.006
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296 (2017).
doi: 10.1038/nmeth.4169 pubmed: 28165473
Tan, Y. Z. et al. Addressing preferred specimen orientation in single-particle cryo-EM through tilting. Nat. Methods 14, 793–796 (2017).
pubmed: 28671674 pmcid: 5533649 doi: 10.1038/nmeth.4347
Liu, F., Lossl, P., Scheltema, R., Viner, R. & Heck, A. J. R. Optimized fragmentation schemes and data analysis strategies for proteome-wide cross-link identification. Nat. Commun. 8, 15473 (2017).
pubmed: 28524877 pmcid: 5454533 doi: 10.1038/ncomms15473

Auteurs

Wen-Ting Lo (WT)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany. lo@fmp-berlin.de.

Yingyi Zhang (Y)

Max Planck Institute for Biophysics, Frankfurt am Main, Germany.
Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt am Main, Germany.
Biological Cryo-EM Center, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong, China.

Oscar Vadas (O)

University of Geneva, Faculty of Medicine, Geneva, Switzerland.

Yvette Roske (Y)

Max Delbrück Centre for Molecular Medicine (MDC), Crystallography, Berlin, Germany.

Federico Gulluni (F)

Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

Maria Chiara De Santis (MC)

Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

Andreja Vujicic Zagar (AV)

University of Geneva, Section of Pharmacy, Geneva, Switzerland.

Heike Stephanowitz (H)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.

Emilio Hirsch (E)

Department of Molecular Biotechnology and Health Sciences, University of Torino, Torino, Italy.

Fan Liu (F)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany.

Oliver Daumke (O)

Max Delbrück Centre for Molecular Medicine (MDC), Crystallography, Berlin, Germany.

Misha Kudryashev (M)

Max Planck Institute for Biophysics, Frankfurt am Main, Germany.
Buchmann Institute for Molecular Life Sciences, Goethe University, Frankfurt am Main, Germany.

Volker Haucke (V)

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP), Berlin, Germany. haucke@fmp-berlin.de.
Department of Biology, Chemistry, Pharmacy, Freie Universität Berlin, Berlin, Germany. haucke@fmp-berlin.de.

Articles similaires

The FGF/FGFR/c-Myc axis as a promising therapeutic target in multiple myeloma.

Arianna Giacomini, Sara Taranto, Giorgia Gazzaroli et al.
1.00
Humans Multiple Myeloma Receptors, Fibroblast Growth Factor Fibroblast Growth Factors Proto-Oncogene Proteins c-myc
Animals Lung India Sheep Transcriptome

Calcineurin inhibition enhances

Priyanka Das, Alejandro Aballay, Jogender Singh
1.00
Animals Caenorhabditis elegans Longevity Caenorhabditis elegans Proteins Calcineurin
1.00
Animals Mice Immunity, Innate Interneurons Synapses

Classifications MeSH